113 related articles for article (PubMed ID: 17488513)
1. Colon cancer risk and different HRT formulations: a case-control study.
Dinger JC; Heinemann LA; Möhner S; Thai do M; Assmann A
BMC Cancer; 2007 May; 7():76. PubMed ID: 17488513
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk associated with different HRT formulations: a register-based case-control study.
Dinger JC; Heinemann LA; Möhner S; Thai do M; Assmann A
BMC Womens Health; 2006 Sep; 6():13. PubMed ID: 16965641
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.
Sit AS; Modugno F; Weissfeld JL; Berga SL; Ness RB
Gynecol Oncol; 2002 Aug; 86(2):118-23. PubMed ID: 12144815
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.
Kotsopoulos J; Huzarski T; Gronwald J; Moller P; Lynch HT; Neuhausen SL; Senter L; Demsky R; Foulkes WD; Eng C; Karlan B; Tung N; Singer CF; Sun P; Lubinski J; Narod SA
Breast Cancer Res Treat; 2016 Jan; 155(2):365-73. PubMed ID: 26780555
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy increases the risk of cranial meningioma.
Andersen L; Friis S; Hallas J; Ravn P; Schrøder HD; Gaist D
Eur J Cancer; 2013 Oct; 49(15):3303-10. PubMed ID: 23800670
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone use and risk of large-bowel cancer.
Newcomb PA; Storer BE
J Natl Cancer Inst; 1995 Jul; 87(14):1067-71. PubMed ID: 7616598
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy with estradiol and risk of venous thromboembolism--a population-based case-control study.
Høibraaten E; Abdelnoor M; Sandset PM
Thromb Haemost; 1999 Oct; 82(4):1218-21. PubMed ID: 10544901
[TBL] [Abstract][Full Text] [Related]
11. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and risk of colon and rectal cancer.
Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
[TBL] [Abstract][Full Text] [Related]
13. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
15. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and risk of glioma: a nationwide nested case-control study.
Andersen L; Friis S; Hallas J; Ravn P; Gaist D
Cancer Epidemiol; 2013 Dec; 37(6):876-80. PubMed ID: 24138870
[TBL] [Abstract][Full Text] [Related]
17. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
18. Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK.
Chilvers CE; Knibb RC; Armstrong SJ; Woods KL; Logan RF
Eur Heart J; 2003 Dec; 24(24):2197-205. PubMed ID: 14659771
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
Mills PK; Riordan DG; Cress RD; Goldsmith DF
Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
[TBL] [Abstract][Full Text] [Related]
20. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
